Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-038963

Director acquired 8,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hatfield Jeffrey S. Director 2026-05-27 Grant or award +8,000 39,806 D
Derivatives
Hatfield Jeffrey S. Director 2026-05-27 Grant or award · Stock Option (Right to Buy) +16,000 16,000 D
Loading xslF345X06/wk-form4_1780010671.xml…